Treatment for metastatic malignant melanoma: old drugs and new strategies

Critical Reviews in Oncology/hematology
Roger MouawadDavid Khayat

Abstract

The number of melanoma cases worldwide is increasing faster than any other cancer and remains one of the most treatment-refractory malignancies. Despite decades of clinical trials testing chemotherapy and immunotherapy, a standard first-line treatment for metastatic melanoma has not yet been established; tough single agent dacarbazine represents the most common option. This review will focus on metastatic malignant melanoma treatment from single agent until new therapies. An overview of established chemotherapies and immunotherapies, followed by a summary of trials testing the potential combination and new agent are explored.

References

Sep 1, 1977·Cancer·M E CostanzaN Sedransk
Feb 11, 1975·Cancer·J J CostanziF C Delaney
Feb 20, 1992·International Journal of Cancer. Journal International Du Cancer·E F McClayR E Bellet
Aug 20, 1992·The New England Journal of Medicine·G CocconiP Costa
Feb 1, 1991·Investigational New Drugs·A I EinzigT J Smith
May 1, 1990·Investigational New Drugs·E S Casper, D Bajorin
Feb 1, 1992·British Journal of Cancer·E S NewlandsM H Brampton
Aug 1, 1991·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C I FalksonH C Falkson
Oct 1, 1990·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D R ParkinsonJ H Doroshow
Oct 1, 1990·American Journal of Clinical Oncology·E BajettaG Zumiani
Dec 1, 1989·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S A RosenbergD E White
Jan 1, 1989·Medical Oncology and Tumor Pharmacotherapy·U RingborgH Strander
Apr 1, 1987·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D GloverD Guerry
Mar 1, 1984·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S D LuikartJ M Kirkwood
Jan 1, 1984·Investigational New Drugs·M LopezA Barduagni
Apr 1, 1984·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J M QuaglianaJ J Costanzi
Jul 1, 1995·Annals of Surgical Oncology·S S Agarwala, J M Kirkwood
Jan 1, 1995·Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progrès Dans Les Recherches Sur Le Cancer·U KeilholzW Hunstein
Jan 1, 1994·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·S AamdalJ Verweij
Apr 1, 1995·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·N M BleehenM F Stevens
Jan 1, 1994·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·D A Vorobiof, W R Bezwoda
Jan 1, 1994·Cancer Investigation·D KhayatJ P Bizzari
Apr 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·E BajettaM G Bernengo
Nov 1, 1993·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D KhayatR Franks
Feb 1, 1993·Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy·R P WhiteheadJ Zeffren
Oct 1, 1993·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J A SparanoG R Weiss
Dec 1, 1995·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A Y BedikianD D Von Hoff
Mar 1, 1996·Current Opinion in Oncology·S S Agarwala, J M Kirkwood
Oct 1, 1996·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S S LeghaN Papadopoulos
Mar 1, 1997·Current Opinion in Oncology·M B Atkins

❮ Previous
Next ❯

Citations

May 12, 2012·The Lancet Oncology·Roger Macklis
Sep 14, 2013·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Chiara MartinoliPier Francesco Ferrucci
Jul 5, 2012·The Pharmacogenomics Journal·A SavonarolaF Silvestris
Jan 5, 2012·Dermatology Research and Practice·Felipe Ades, Otto Metzger-Filho
Nov 26, 2015·The Journal of General Virology·Dominique BollinoLaure Aurelian
Mar 10, 2015·Translational Oncology·Stephen A RosenbergJames S Goydos
Nov 30, 2010·Surgical Oncology Clinics of North America·Jade HomsiPatrick Hwu
May 28, 2010·The Journal of Investigative Dermatology·Maithao N LeJames S Goydos
Mar 16, 2016·Clinical and Experimental Otorhinolaryngology·Raphaela Silva Leandro SantosDanyel Elias da Cruz Perez
Feb 24, 2012·Journal of Digestive Diseases·Hiroyuki MatsubayashiHiroyuki Ono
Mar 1, 2013·The British Journal of Dermatology·A C J van Akkooi, T Nijsten
Jan 13, 2012·Veterinary and Comparative Oncology·N YamadaK Maruo
Jan 21, 2015·Fundamental & Clinical Pharmacology·Laure-Anais VincentPierre Cuq
Feb 8, 2011·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Maria J SambadeJaniel M Shields
Feb 26, 2013·Expert Opinion on Pharmacotherapy·April K S Salama, Kevin B Kim
Feb 20, 2014·Oral Oncology·Yunteng WuGuoxin Ren
Mar 5, 2011·Trends in Immunology·Maureen A CoxAllan J Zajac
Dec 3, 2014·Cancer Letters·Tommaso AzzaritoStefano Fais
Oct 4, 2016·Biochemical and Biophysical Research Communications·Fernanda AntunesSoraya Smaili
Oct 23, 2016·International Journal of Cancer. Journal International Du Cancer·Guillaume SarrabayrouseAnne Françoise Tilkin-Mariame
Mar 25, 2017·International Journal of Cancer. Journal International Du Cancer·Jian-Qin TangGuan Jiang
Jul 12, 2013·Clinical Medicine Insights. Oncology·April K S Salama
Sep 9, 2011·Melanoma Research·Roger MouawadDavid Khayat
Nov 4, 2010·Melanoma Research·Roger MouawadDavid Khayat
Jun 28, 2011·The Journal of Biological Chemistry·Carmen BediaThierry Levade
Aug 21, 2013·ChemMedChem·Ana Marta Matos, Ana Paula Francisco
Mar 23, 2017·Cell Biology International·Ning LiDaping Yang
Aug 10, 2017·BMC Health Services Research·Jérôme FernandesAnne-Françoise Gaudin

❮ Previous
Next ❯

Related Concepts

Related Feeds

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.